|||||**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||**From**|||Period start date|||||||**To**||Period end date||||||
||||||||01|04||||2024||||31|03||||2025|
|||||||||||||||||||||||
|Section A|||Reference and administration details|||||||||||||||||||
|||||||||||||||||||||||
||||**Charity name**|||||||Myodesopsia International||||||||||||
|||||||||||||||||||||||
||||**Other names charity is known by**|||||||||||||||||||
|||||||||||||||||||||||
||||**Registered charity number(if any) **|||||||1202141||||||||||||
|||||||||||||||||||||||
||||**Charity's principal address**||||||||4th Floor, Silverstream House|||||||||||
||||||||||||45 Fitzroy Street, Fitzrovia|||||||||||
||||||||||||London|||||||||||
||||||||||||**Postcode**||||||||WT1 6EB|||
|||||||||||||||||||||||
||**Names of the charity trustees who manage the charity**|||||||||||||||||||||
||||**Trustee name**||**Office (if any)**||||||||**Dates acted if not for**<br>**whole year**|||||||**Name of person (or**<br>**body) entitled to appoint**<br>**trustee (if any)**||
|1|||Dymock Brett||Chair|||||||||||||||||
|2|||Matthew Mazewski|||||||||||||||||||
|3|||Alaster Moffat|||||||||||||||||||
||||**Names of the trustees for the charity, if any, (for example, any custodian trustees)**|||||||||||||||||||
||||**Name**||||||||||**Dates acted if not for whole year**|||||||||
|||||||||||||||||||||||
|||||||||||||||||||||||
|||||||||||||||||||||||



## **Names and addresses of advisers (Optional information)** 

**Type of adviser Name Address** 

## **Name of chief executive or names of senior staff members (Optional information)** 

## **Section B              Structure, governance and management** 

## **Description of the charity’s trusts** 

Type of governing document 

Constitution 

(eg. trust deed, constitution) 

1 



|How the charity is constituted|Charitable Incorporated Organisation – Association Model (CIO)|Charitable Incorporated Organisation – Association Model (CIO)||
|---|---|---|---|
|(eg. trust, association, company)||||
|Trustee selection methods<br>(eg. appointed by, elected by)|Elected by the membership at annual general meetings (AGMs) or appointed<br>by trustees for specific purposes between AGMs.|||
|**Additional governance issues (Optional information)**||||
|You**may choose**to include<br>additional information, where<br>relevant, about:|Given the small size of the Charity, all Trustees performed executive functions<br>in addition to their governance duties during the period considered. The focus<br>of the Board has been to continue to scale the Charity’s capacity in<br>furtherance of its charitable objects, and to ensure the financial stability of the|||
|● policies and procedures|organisation.|||
|adopted for the induction<br>and training of trustees;|The Charity was able to formally open membership to the public during the|||
|● the charity’s organisational<br>structure and any wider|period considered, implementing a membership management system that is<br>compliant with GDPR and other relevant legislation.|||
|network with which the<br>charity works;<br>● relationship with any<br>related parties;<br>● trustees’ consideration of<br>major risks and the system<br>and procedures to manage<br>them.|At the Charity’s first AGM with non-Trustee members (held in March 2025),<br>amendments to the Charity’s governing document were approved which<br>made explicit provisions for electronic voting and virtual meetings.<br>The Board of Trustees continued to consult with experts on governance, data<br>protection, organisational scaling, and fundraising, as well as with medical<br>and scientific professionals to further the advancement of the Charity’s<br>objects while strictly adhering to all relevant regulations.|||
|||||
|**Section C**|**Objectives and activities**|||
|**Summary of the objects of the**<br>**charity set out in its governing**<br>**document**||1) To preserve and protect the health of individuals diagnosed with<br>myodesopsia (also known as eye floaters or symptomatic vitreous floaters)<br>in particular by:<br>A) promoting, supporting, sponsoring, and commissioning research into the|<br>|
|||diagnosis, understanding and treatment of the condition.||
|||B) facilitating collaboration between patients, clinicians, and researchers in||
|||order to improve understanding of the condition and the patient experience.||
|||C) providing up-to-date and relevant information to individuals diagnosed||
|||with the condition and to medical professionals as a means of improving||
|||understanding and raising awareness of myodesopsia.||
|||2) To relieve the needs of people diagnosed with myodesopsia, and by||
|||extension their families and carers, by providing assistance in the form of||
|||support networks for the patient community.||



2 



|**Summary of the main activities**||
|---|---|
|**undertaken for the public**|The Trustees, in exercising their powers as elected representatives of|
|**benefit in relation to these**|Myodesopsia International, have had due regard for the Charity|
|**objects (include within this**|Commission’s guidance on public benefit.|
|**section the statutory**||
|**declaration that trustees have**|In general, the major activities of the Charity in the period considered were|
|**had regard to the guidance**|aimed at opening membership to the general public, increasing capacity of|
|**issued by the Charity**|the organisation, and establishing procedures that will allow it to continue|
|**Commission on public benefit)**|successfully after the tenure of the current Trustees. In particular:|
||• In pursuance of object 1(B), the Charity and Trustees have maintained|
||open lines of communication with a number of medical professionals with|
||expertise on myodesopsia and have explored possibilities for future|
||collaboration. The Trustees believe that the building of a patient-physician|
||network will be crucial to improving the understanding of the condition and|
||the patient experience.|
||• In pursuance of object 1(A), the Charity and its volunteers were involved|
||in developing a questionnaire for a large-scale prevalence study of|
||myodesopsia in the general population of the United States of America,|
||co-led by Trustee Matthew Mazewski.|
||• In pursuance of object 1(C), the online research repository hosted on the|
||Charity’s website was expanded and kept up to date with the help of a|
||volunteer.<br>• The Charity recruited a volunteer Creative Director, who has begun to|
||guide the Charity’s dissemination strategy for public-facing materials, and|
||has enhanced the professionalism of its content and communications. This|
||has resulted in improvements in style and clarity, making the relevant|
||information for patients easier to find.|
||• In pursuance of objects 1(C) and 2, the Charity began a regular email|
||newsletter to its members, managed by a newly recruited volunteer.|



## **Additional details of objectives and activities (Optional information)** 

You **may choose** to include further statements, where relevant, about: 

- policy on grantmaking; 

- policy programme related investment; 

- ● contribution made by volunteers. 

3 



Section D                      Achievements and performance 

|Section D                      Achievements andperformance|Section D                      Achievements andperformance|
|---|---|
|||
|**Summary of the main**<br>**achievements of the charity**<br>**during the year**|-<br>The Charity held its first AGM in July 2024. At that time, the only<br>members were the Charity Trustees, as it had not yet been<br>possible to implement a membership management system that<br>protected the privacy and data of members to the satisfaction of<br>the Trustees. However, a data security expert had been consulted<br>and advised Trustees on how to proceed. At the AGM, it was<br>confirmed that, despite low income, the Charity was in a<br>sustainable financial position. The main focus of the Charity was<br>to open membership to the general public.<br>-<br>The Charity was able to formally open membership to the wider<br>public in January 2025, employing a membership management<br>system that protects members’ data in a GDPR-compliant manner<br>-<br>The Charity held its first AGM with non-Trustee members in<br>March 2025, at which charity members were given the opportunity<br>to share their perspectives on what they thought the areas of<br>focus for the Charity should be in the coming year. The strong<br>alignment between the existing priorities and those voted on by<br>members suggests that the Charity is continuing to meet genuine<br>needs of the community.<br>-<br>Three new volunteers joined the Charity during this period,<br>doubling the number of volunteers and expanding the collective<br>skillset. The areas of expertise of the new volunteers show strong<br>alignment with the Charity’s requirements.<br>-<br>The Charity’s members approved amendments to the<br>Constitution, making more explicit the provisions for virtual<br>meetings and electronic voting. This is key to ensuring the Charity<br>can continue to operate on its current scale with its current level<br>of income.<br>-<br>The Charity started developing professional audiovisual materials,<br>including graphics and video content, with the help of a volunteer<br>Creative Director.|



4 



**Section E                    Financial review** 

|**Section E                    Financial review**|**Section E                    Financial review**|
|---|---|
|||
|**Brief statement of the**<br>**charity’s policy on reserves**|Given the small amount of funds held by the Charity at any one time, with<br>costs covered on a monthly basis, the Charity does not currently have a<br>reserves policy. The main benefits provided to beneficiaries at present<br>are provided through the Charity’s website, which is paid for each year in<br>advance, at very low cost. The Board of Trustees reviews the Charity’s<br>financial situation formally every quarter, and informally on a weekly<br>basis, ensuring that all costs are covered. In light of the low ongoing<br>costs, the small amount of funds held by the Charity at any one time<br>(<£1000), and the regular monitoring of the Charity’s finances, the<br>Trustees feel that a reserves policy is unnecessary at present.|
|**Details of any funds materially**<br>**in deficit**|<br>None|
|**Further financial review details (Optional information)**||
|You**may choose**to include<br>additional information, where<br>relevant about:<br>● the charity’s principal<br>sources of funds (including<br>any fundraising);<br>● how expenditure has<br>supported the key objectives<br>of the charity;<br>● investment policy and<br>objectives including any<br>ethical investment policy<br>adopted.|During the period considered, the Charity was principally funded through<br>small donations from Trustees and volunteers. From January 2025, the<br>Charity began to collect membership fees, which rapidly became the<br>main source of income for the Charity.<br>The main sources of expenditure during the period considered have been<br>the maintenance of a physical address and the hosting of a website. The<br>Charity’s website is a key tool for enabling it to pursue its objects,<br>allowing low-cost dissemination of knowledge about the condition to the<br>general public. The increase in available funds following the opening of<br>membership to the public allowed the Charity to start exploring the<br>production of higher-quality materials, pursuant to objects 1B and 1C,<br>although no funds were used for these purposes during this time.<br>At present, the Charity holds no investments.|



5 



**Section F                     Other optional information** 

## **Section G                    Declaration** 

**The trustees declare that they have approved the trustees’ report above. Signed on behalf of the charity’s trustees** 

|**Section G                    Declaration**|**Section G                    Declaration**|**Section G                    Declaration**|
|---|---|---|
|**The trustees declare that they have approved the trustees’ report above.**<br>**Signed** **on behalf of the charity’s trustees**|||
|**Signature(s)**|||
|**Full name(s)**|Dymock Brett||
|**Position (eg Secretary, Chair, etc)**|Chair||
|**Date**|9 Dec 2025||



Template source: https://assets.publishing.service.gov.uk/media/5a7ef6e340f0b62305b84487/tar.doc 

6 



**Myodesopsia International 1202141** 

**CC16a** 


**Receipts and payments accounts For the period** 1/4/2024 31/3/2025 **To from** 

## **Section A Receipts and payments** 

|**Myodesopsia International**<br>**CC16a**<br>**1202141**<br>**Receipts and payments accounts**<br>**For the period**<br>**from**<br>1/4/2024<br>**To**<br>31/3/2025<br>**Section A Receipts and payments**|**Myodesopsia International**<br>**CC16a**<br>**1202141**<br>**Receipts and payments accounts**<br>**For the period**<br>**from**<br>1/4/2024<br>**To**<br>31/3/2025<br>**Section A Receipts and payments**|**Myodesopsia International**<br>**CC16a**<br>**1202141**<br>**Receipts and payments accounts**<br>**For the period**<br>**from**<br>1/4/2024<br>**To**<br>31/3/2025<br>**Section A Receipts and payments**|**Myodesopsia International**<br>**CC16a**<br>**1202141**<br>**Receipts and payments accounts**<br>**For the period**<br>**from**<br>1/4/2024<br>**To**<br>31/3/2025<br>**Section A Receipts and payments**|**Myodesopsia International**<br>**CC16a**<br>**1202141**<br>**Receipts and payments accounts**<br>**For the period**<br>**from**<br>1/4/2024<br>**To**<br>31/3/2025<br>**Section A Receipts and payments**|**Myodesopsia International**<br>**CC16a**<br>**1202141**<br>**Receipts and payments accounts**<br>**For the period**<br>**from**<br>1/4/2024<br>**To**<br>31/3/2025<br>**Section A Receipts and payments**|**Myodesopsia International**<br>**CC16a**<br>**1202141**<br>**Receipts and payments accounts**<br>**For the period**<br>**from**<br>1/4/2024<br>**To**<br>31/3/2025<br>**Section A Receipts and payments**|**Myodesopsia International**<br>**CC16a**<br>**1202141**<br>**Receipts and payments accounts**<br>**For the period**<br>**from**<br>1/4/2024<br>**To**<br>31/3/2025<br>**Section A Receipts and payments**|**Myodesopsia International**<br>**CC16a**<br>**1202141**<br>**Receipts and payments accounts**<br>**For the period**<br>**from**<br>1/4/2024<br>**To**<br>31/3/2025<br>**Section A Receipts and payments**|**CC16a**|
|---|---|---|---|---|---|---|---|---|---|
|**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**A1 Receipts**|||**Restricted funds**<br>**to the nearest £**||**Endowment**<br>**funds**<br>**to the nearest £**||**Total funds**<br>**to the nearest £**||**Last year**<br>**to the nearest £**|
|Trustee Donations|**-**<br>**272-**|**- **|**-**<br>**--**||**-**<br>**--**||**-**<br>**272-**||**-**<br>**--**|
|Membership Fees|**-**<br>**647-**||**-**<br>**--**||**-**<br>**--**||**-**<br>**647-**||**-**<br>**--**|
|Subscription Donations|**-**<br>**66-**||**-**<br>**--**||**-**<br>**--**||**-**<br>**66-**||**-**<br>**--**|
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
|**_Sub total_**_(Gross income for AR)_**-**<br>**985-**<br>**A2 Asset and investment sales,**<br>**(see table).**|**-**<br>**985-**||**-**<br>**--**||**-**<br>**--**||**-**<br>**985-**||**-**<br>**--**|
|||||||||||
|**A2 Asset and investment sales,**<br>**(see table).**||||||||||
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|||
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
|**_Sub total_-**<br>**--**<br>**_Total receipts_ -**<br>**985-**<br>**A3 Payments**|**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
|||||||||||
||**-**<br>**985-**||**-**<br>**--**||**-**<br>**--**||**-**<br>**985-**||**-**<br>**--**|
|||||||||||
|Bank Fees|**-**<br>**60-**||**-**<br>**--**||**-**<br>**--**||**-**<br>**60-**||**-**<br>**--**|
|IT Costs|**-**<br>**16-**||**-**<br>**--**||**-**<br>**--**||**-**<br>**16-**||**-**<br>**--**|
|Virtual Office|**-**<br>**238-**||**-**<br>**--**||**-**<br>**--**||**-**<br>**238-**||**-**<br>**--**|
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
|**_Sub total_ -**<br>**314-**<br>**A4 Asset and investment**<br>**purchases, (see table)**|**-**<br>**314-**||**-**<br>**--**||**-**<br>**--**||**-**<br>**314-**||**-**<br>**--**|
|||||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**||||||||||
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|||
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|||
|**_Sub total_ -**<br>**--**<br>**_Total payments_ -**<br>**314-**<br>**_Net of receipts/(payments)_ -**<br>**671-**<br>**A5 Transfers between funds**<br>**-**<br>**--**<br>**A6 Cash funds last year end**<br>**-**<br>**26-**<br>**_Cash funds this year end_ -**<br>**697-**|**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|||
|||||||||||
||**-**<br>**314-**||**-**<br>**--**||**-**<br>**--**||**-**<br>**314-**||**-**<br>**--**|
|||||||||||
||**-**<br>**671-**||**-**<br>**--**||**-**<br>**--**||**-**<br>**671-**||**-**<br>**--**|
||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
||**-**<br>**26-**||**-**<br>**--**||**-**<br>**--**||**-**<br>**26-**||**-**<br>**--**|
||**-**<br>**697-**||**-**<br>**--**||**-**<br>**--**||**-**<br>**697-**||**-**<br>**--**|
|||||||||||



CCXX R1 accounts (SS) 

09/12/2025 

1 



## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>**B1 Cash funds**|**Details**|**Details**|**Unrestricted**<br>**funds**<br>**to nearest £**|**Unrestricted**<br>**funds**<br>**to nearest £**|**Restricted funds**<br>**to nearest £**|**Restricted funds**<br>**to nearest £**|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|---|---|---|---|
||Cash||**-**<br>**697-**||**-**<br>**--**||**-**<br>**--**|
||||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
||||**-**<br>**--**||**-**<br>**--**||**-**<br>**--**|
|**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B5 Liabilities**<br>Signed by one or two trustees on behalf of<br>all the trustees|**_Total cash funds_**<br>(agree balances with receipts and payments account<br>(s))<br>**Details**<br>**Details**||**-**<br>**697-**||**-**<br>**--**||**-**<br>**--**|
||||||||OK|
||||**Unrestricted**<br>**funds**<br>**to nearest £**<br>**-**<br>**--**<br>**-**<br>**--**<br>**-**<br>**--**<br>**-**<br>**--**<br>**-**<br>**--**<br>**-**<br>**--**<br>**Fund to which asset**<br>**belongs**||**Restricted funds**<br>**to nearest £**<br>**-**<br>**--**<br>**-**<br>**--**<br>**-**<br>**--**<br>**-**<br>**--**<br>**-**<br>**--**<br>**-**<br>**--**<br>**Cost (optional)**<br>**-**<br>**--**<br>**-**<br>**--**||**Endowment**<br>**funds**<br>**to nearest £**|
||||||||**-**<br>**--**|
||||||||**-**<br>**--**|
||||||||**-**<br>**--**|
||||||||**-**<br>**--**|
||||||||**-**<br>**--**|
||||||||**-**<br>**--**|
||||||||**Current value**<br>**(optional)**|
||||||**-**<br>**--**||**-**<br>**--**|
||||||**-**<br>**--**||**-**<br>**--**|
||||||**-**<br>**--**||**-**<br>**--**|
||||||**-**<br>**--**||**-**<br>**--**|
||||||**-**<br>**--**||**-**<br>**--**|
||||||||**Current value**<br>**(optional)**|
||||||||**20/year**|
||||||||**20/year**|
||||||||**-**<br>**--**|
|||||||||
||||||||**-**<br>**--**|
||||||||**-**<br>**--**|
||||||||**-**<br>**--**|
||||||||**-**<br>**--**|
||||||||**-**<br>**--**|
||||||||**-**<br>**--**|
||||||||**When due**<br>**(optional)**|
|||||||||
|||||||||
|||||||||
|||||||||
|||||||||
||||||||Date of approval|
||||||||9 Dec 2025|



CCXX R2 accounts (SS) 

09/12/2025 

2 

